HopeStage
Back to all studies
RecruitingNCT04131829

Brain activity linked to medication response in OCD

About this titleRead the official source — NCT04131829
Medication studyAges 18–65United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

What will I do during this study?

Healthy control participants have one fMRI scan at baseline. Participants with OCD are randomly assigned to start fluoxetine straight away or after a six-week placebo (an inactive comparison treatment) lead-in. They have fMRI scans at baseline and during treatment. The record does not specify the number or length of treatment visits.

Listed locations
New HavenSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 14, 2019
Recruitment status
Recruiting
Enrollment listed in the registry
100
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT04131829
Official title
Show the full official title

Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD

Recruitment & locations

Currently recruiting

New Haven

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Does this study involve medication?

Yes. The study involves medication, including Fluoxetine - immediate treatment and Fluoxetine - delayed treatment.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies